86
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia–reperfusion injury

, , , , , , , , & show all
Pages 875-888 | Published online: 30 Jan 2019

References

  • DongóEHornyákIBenkőZKissLThe cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (review)Acta Physiol Hung201198436938122173019
  • NicholsonCKCalvertJWHydrogen sulfide and ischemia-reperfusion injuryPharmacol Res201062428929720542117
  • ElrodJWCalvertJWMorrisonJHydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial functionProc Natl Acad Sci U S A200710439155601556517878306
  • CaliendoGCirinoGSantagadaVWallaceJLSynthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticalsJ Med Chem201053176275628620462257
  • YuLLiSTangXDiallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activationApoptosis201722794295428455824
  • GuoCSunXKongBMesoporous silica nanoparticles for glutathione-triggered long-range and stable releasing hydrogen sulfideJ Mater Chem B201532144514457
  • SunXWangWDaiJA long-term and slow-releasing hydrogen sulfide donor protects against myocardial ischemia/reperfusion injuryScientific Reports20177354128615705
  • WangWTaoHZhaoYImplantable and biodegradable macroporous iron oxide frameworks for efficient regeneration and repair of infracted heartTheranostics2017771966197528638482
  • WangWSunXZhangHControlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia-reperfusion injuryInt J Nanomedicine2016113255326327486324
  • YaoLLHuangXWWangYGCaoYXZhangCCZhuYCHydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTPAm J Physiol Heart Circ Physiol20102985H1310H131920154265
  • LiLWhitemanMGuanYYCharacterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfideCirculation2008117182351236018443240
  • MengGWangJXiaoYGYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in ratsJ Biomed Res201529320321326060444
  • PatilASinghSOpereCDashASustained-release delivery system of a slow hydrogen sulfide donor, gyy 4137, for potential application in glaucomaAAPS PharmSciTech20171862291230228101725
  • AliHOpereCSinghSIn vitro-controlled release delivery system for hydrogen sulfide donorAAPS PharmSciTech201415491091924760470
  • GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials200526183995402115626447
  • FreiEHMagnetism and medicineJ Appl Phys1969403955957
  • AlexiouCArnoldWKleinRJLocoregional cancer treatment with magnetic drug targetingCancer Res200060236641664811118047
  • ForgeDLaurentSGossuinYRochAvander ElstLMullerRNAn original route to stabilize and functionalize magnetite nanoparticles for theranosis applicationsJ Magn Magn Mater20113235410415